This is a supplement to EyeWorld Magazine that doctors can take a test after reading and receive CME credits for.
Issue link: http://cmesupplements.eyeworld.org/i/753219
Supported by ..... EyeWorld December 2016 Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continu- ing Medical Education through the joint providership of the American Society of Cataract and Refractive Surgery (ASCRS) and EyeWorld. ASCRS is accredited by the ACCME to provide continuing medical education for physicians. Educational Objectives Ophthalmologists who participate in this activity will: • Identify different pathways and models that permit the viable integration of LACS into a refractive cataract practice: accessibility pathways, reimbursement models for technology access, and practice flow models in a variety of settings; and • Develop customized practice adoption plans for advanced technologies: protocols for staff training and proper patient conversation techniques for expectation management and accep- tance of technology. Designation Statement The American Society of Cataract and Refractive Surgery designates this enduring materials educational activity for a maximum of 1.0 AMA PRA Category 1 Credits. ™ Physicians should claim only credit commensurate with the extent of their participation in the activity. Claiming Credit To claim credit, participants must visit bit.ly/2ffsgw8 to review content and download the post-activity test and credit claim. All participants must pass the post-activity test with a score of 75% or higher to earn credit. Alternatively, the post-test form included in this monograph may be faxed to the number indicated for credit to be awarded, and a certificate will be mailed within 2 weeks. When viewing online or downloading the material, standard internet access is required. Adobe Acrobat Reader is needed to view the materials. CME credit is valid through May 31, 2017. CME credit will not be awarded after that date. Notice of Off-Label Use Presentations This activity may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. ADA/Special Accommodations ASCRS and EyeWorld fully comply with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. Any participant in this educational program who requires special accommodations or services should contact Laura Johnson at ljohnson@ascrs. org or 703-591-2220. Financial Interest Disclosures David Dillman, MD, has received a retain- er, ad hoc fees or other consulting income from Alcon Laboratories and Sightpath Medical. Gary Foster, MD, has an investment interest in AcuFocus and Alphaeon. He has received research funding from Alcon Laboratories, Bausch + Lomb, and Ivantis. Dr. Foster has received a retainer, ad hoc fees or other consulting income from and is a member of the speakers bureau of Alcon Laboratories. Steven Slade, MD, has an investment in- terest in Novartis and RVO. He has received a retainer, ad hoc fees or other consulting income from: Alcon Laboratories, Bausch + Lomb, Carl Zeiss Meditec, and Clarity Medical. Elizabeth Yeu, MD, has an investment interest in Modernizing Medicine and RPS. She has received a retainer, ad hoc fees or other consulting income from and is a member of the speakers bureau of: Abbott Medical Optics, Alcon Laboratories, Allergan, Bio-Tissue, i-Optics, Shire, and TearLab. Dr. Yeu has received a retainer, ad hoc fees or other consulting income from: ArcScan, Bausch + Lomb, Kala, Ocular Therapeutix, OcuSoft, and Omeros. She has received research funding from: Bio-Tissue, i-Optics, Kala, and Topcon. Staff members: Kristen Covington and Laura Johnson have no ophthalmic-related financial interests. Methods for making laser-assisted cataract surgery fit in your practice Laser-assisted cataract surgery (LACS) 365 Curriculum continued on page 2 by Stephen Slade, MD Financing femto: Breaking even with direct acquisition permanence and commitment to patients. Although we initially began using the femtosecond laser during our investigational work, we did not know how often we would use it in our practice. Ulti- mately, our patient volume grew significantly. I consider femtosec- ond laser-assisted cataract surgery to be an excellent practice builder. femtosecond laser for our ambu- latory surgery center. With this option, the laser would be more available, making procedures more convenient and accessible for our patients. Because we own our laser, we can perform femto- second procedures at any time, without relying on someone else's schedule. This offers us greater independence. I also think that owning our laser indicates our Surgeon details points to consider before purchasing femto laser A s laser and lens technology advances, more cataract surgeons are considering the jump to femtosecond laser-assisted cataract surgery. For a number of reasons, pur- chasing a femtosecond laser was the right choice for our practice, but each surgeon needs to take a look at his or her own practice to establish whether this is a viable option. This article shares the process we used when analyzing this investment. Practical advantages Rather than sharing laser access or using a mobile equipment service, we chose to purchase a Practice pearl: Do your homework to ensure financial success with a femtosecond laser for cataract surgery. A simple pro forma including your number of cases, direct expenses, etc., will go a long way in guiding your decision. Also take a careful look at your available space options and needs for the laser. –Stephen Slade, MD " By developing the pro forma, we knew what to expect as we proceeded. " –Stephen Slade, MD Supported by an unrestricted educational grant from Abbott Medical Optics Click to read and claim CME credit